Re: Duration of Androgen Suppression before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910 Editorial Comment

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 01期
关键词：
D O I：
10.1016/j.juro.2015.10.057
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [1] Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910
    Pisansky, Thomas M.
    Hunt, Daniel
    Gomella, Leonard G.
    Amin, Mahul B.
    Balogh, Alexander G.
    Chinn, Daniel M.
    Seider, Michael J.
    Duclos, Marie
    Rosenthal, Seth A.
    Bauman, Glenn S.
    Gore, Elizabeth M.
    Rotman, Marvin Z.
    Lukka, Himanshu R.
    Shipley, William U.
    Dignam, James J.
    Sandler, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (04) : 332 - U195
  • [2] Re: Tadalafil for Prevention of Erectile Dysfunction after Radiotherapy for Prostate Cancer: The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial Editorial Comment
    Taneja, Samir S.
    Penson, David F.
    JOURNAL OF UROLOGY, 2014, 192 (06): : 1663 - 1664
  • [3] Re: Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer: The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial
    Langille, Gavin M.
    Kovac, Jason R.
    Ramasamy, Ranjith
    Dupree, James M.
    Lipshultz, Larry I.
    EUROPEAN UROLOGY, 2014, 66 (03) : 594 - 595
  • [4] Radiation Therapy Oncology Group 9910: Phase 3 Trial to Evaluate the Duration of Neoadjuvant (NEO) Total Androgen Suppression (TAS) and Radiation Therapy (RT) in. Intermediate-Risk Prostate Cancer (PCa)
    Pisansky, T. M.
    Hunt, D.
    Gomella, L. G.
    Amin, M. B.
    Balogh, A. G.
    Chinn, D. M.
    Seider, M.
    Duclos, M.
    Rosenthal, S. A.
    Sandler, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S1 - S1
  • [5] Duration of Androgen Suppression in the Treatment of Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2312 - 2313
  • [6] Re: Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2012, 187 (03): : 910 - 910
  • [7] Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial
    Pisansky, Thomas M.
    Pugh, Stephanie L.
    Greenberg, Richard E.
    Pervez, Nadeem
    Reed, Daniel R.
    Rosenthal, Seth A.
    Mowat, Rex B.
    Raben, Adam
    Buyyounouski, Mark K.
    Kachnic, Lisa A.
    Bruner, Deborah W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (13): : 1300 - 1307
  • [8] Re: Effectiveness of Primary Androgen-Deprivation Therapy for Clinically Localized Prostate Cancer Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2014, 192 (05): : 1422 - 1422
  • [9] Re: Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2014, 191 (04): : 983 - 983
  • [10] A RANDOMIZED TRIAL (IRISH CLINICAL ONCOLOGY RESEARCH GROUP 97-01) COMPARING SHORT VERSUS PROTRACTED NEOADJUVANT HORMONAL THERAPY BEFORE RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER
    Armstrong, John G.
    Gillham, Charles M.
    Dunne, Mary T.
    Fitzpatrick, David A.
    Finn, Marie A.
    Cannon, Mairin E.
    Taylor, Judy C.
    O'Shea, Carmel M.
    Buckney, Steven J.
    Thirion, Pierre G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (01): : 35 - 45
12345